SLNO insider buying and SEC filings, explained
Soleno Therapeutics Inc. · CIK 1484565
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$429K
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Mar 27, 2026 | Sale | Michael F. Huang (Sr. VP of Clinical Development) sold 6,582 shares at about $30.44 ($200K). Holdings down 14% to 39,823 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 31, 2026 |
| Mar 27, 2026 | Sale | Meredith Manning (Chief Commercial Officer) sold 7,522 shares at about $30.44 ($229K). Holdings down 10% to 64,507 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 31, 2026 |
30 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow SLNO in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.